Your search returned 110 studies. (Get alerts for new studies):
- A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone R
Conditions: Neoplasms, Breast
Location: Waterloo, Iowa
- "Effect of High Fat and High Glycemic Diets
Conditions: Type 2 Diabetes
Location: Rochester, Minnesota
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: Chillicothe, Ohio
- ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
Conditions: Neoplasms, Breast - Breast Cancer
Location: Chillicothe, Ohio
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: La Crosse, Wisconsin
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: La Crosse, Wisconsin
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: La Crosse, Wisconsin
- Glycoprotein and Glycan in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal L
Conditions: Cervical Cancer
Location: La Crosse, Wisconsin
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: La Crosse, Wisconsin
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: La Crosse, Wisconsin
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: La Crosse, Wisconsin
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: La Crosse, Wisconsin
- Detection of Left Atrial Appendage (LAA) Thrombus: Comparison of Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiogram
Conditions: Left Atrial Appendage Thrombi
Location: La Crosse, Wisconsin
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: La Crosse, Wisconsin
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: La Crosse, Wisconsin
- BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non
Conditions: Lung Cancer
Location: La Crosse, Wisconsin
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: La Crosse, Wisconsin
- Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Location: La Crosse, Wisconsin
- Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
Conditions: Brain and Central Nervous System Tumors
Location: La Crosse, Wisconsin
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: La Crosse, Wisconsin
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: La Crosse, Wisconsin
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Conditions: Neuroblastoma
Location: La Crosse, Wisconsin
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Conditions: Chordoma - Desmoid Tumor - Sarcoma
Location: La Crosse, Wisconsin
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Conditions: Brain and Central Nervous System Tumors
Location: La Crosse, Wisconsin
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: La Crosse, Wisconsin
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: La Crosse, Wisconsin
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: La Crosse, Wisconsin
- Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors - Neurotoxicity
Location: La Crosse, Wisconsin
- Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: La Crosse, Wisconsin
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute M
Conditions: Leukemia
Location: La Crosse, Wisconsin
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Ovarian Mucinous Cystadenocarcinoma - Ovarian Mucinous Cystadenoma With Proliferating Activity - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Stage IA Fallopian Tube Cancer - Stage IA Ovarian Epithelial Cancer - Stage IB Fallopi
Location: La Crosse, Wisconsin
- Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
Conditions: Malignant Mesothelioma
Location: La Crosse, Wisconsin
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Conditions: Cervical Cancer
Location: La Crosse, Wisconsin
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: La Crosse, Wisconsin
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: La Crosse, Wisconsin
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: La Crosse, Wisconsin
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Conditions: Diarrhea - Gastrointestinal Complications - Unspecified Adult Solid Tumor, Protocol Specific
Location: La Crosse, Wisconsin
- Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-
Conditions: Lymphoma
Location: La Crosse, Wisconsin
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: La Crosse, Wisconsin
- A Study of the Efficacy and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who
Conditions: Chronic Idiopathic Urticaria
Location: La Crosse, Wisconsin
- Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Conditions: Head and Neck Cancer - Precancerous Condition
Location: La Crosse, Wisconsin
- Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma
Location: La Crosse, Wisconsin
- Varenicline Treatment for Active Alcoholic Smokers
Conditions: Smoking - Tobacco Dependence - Alcohol Dependence
Location: LaCrosse, Wisconsin
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: La Crosse, Wisconsin
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavit
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: La Crosse, Wisconsin
- Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: La Crosse, Wisconsin
- Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: La Crosse, Wisconsin
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: La Crosse, Wisconsin
- Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mant
Conditions: Lymphoma - Neurotoxicity - Therapy-related Toxicity
Location: La Crosse, Wisconsin
- Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
Conditions: Breast Cancer - Cancer Survivor - Hot Flashes
Location: La Crosse, Wisconsin
- Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Conditions: Prostate Cancer
Location: La Crosse, Wisconsin
- Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
Conditions: Breast Cancer
Location: La Crosse, Wisconsin
- Validation of a Clinical Prediction Rule to Identify Patients With Shoulder Pain Likely to Benefit From Cervicothoracic Manipulation: A Randomized Cli
Conditions: Shoulder Pain
Location: Onalaska, Wisconsin
- Study of Cardiovascular Disease and Obstructive Sleep Apnea
Conditions: Severe Obstructive Sleep Apnea (Apnea Hypopnea Index > 30 Events/Hour) - Hypertension
Location: LaCrosse, Wisconsin
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: La Crosse, Wisconsin
- Myocardial Performance at Rest and During Exercise in Heart Failure With Preserved Ejection Fraction
Conditions: Heart Failure With Preserved Ejection Fraction
Location: La Crosse, Wisconsin
- Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastom
Conditions: Brain Tumor - Central Nervous System Tumor
Location: La Crosse, Wisconsin
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: La Crosse, Wisconsin
- Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES)
Conditions: Hypereosinophilic Syndrome
Location: Onalaska, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: La Crosse, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: La Crosse, Wisconsin
- Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer
Location: La Crosse, Wisconsin
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Onalaska, Wisconsin
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: La Crosse, Wisconsin
- ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
Conditions: Neoplasms, Breast - Breast Cancer
Location: La Crosse, Wisconsin
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Conditions: Endometrial Cancer
Location: La Crosse, Wisconsin
- Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Prima
Conditions: Brenner Tumor - Fallopian Tube Cancer - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated A
Location: La Crosse, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
Location: La Crosse, Wisconsin
- Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Conditions: Lung Cancer
Location: La Crosse, Wisconsin
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: La Crosse, Wisconsin
- A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Followi
Conditions: B-cell Chronic Lymphocytic Leukemia
Location: La Crosse, Wisconsin
- Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Conditions: Multiple Myeloma - Plasma Cell Neoplasm
Location: La Crosse, Wisconsin
- Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Location: La Crosse, Wisconsin
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: La Crosse, Wisconsin
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: La Crosse, Wisconsin
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
Location: La Crosse, Wisconsin
- Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: La Crosse, Wisconsin
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Cape
Conditions: Adenocarcinoma of the Pancreas - Stage I Pancreatic Cancer - Stage II Pancreatic Cancer
Location: La Crosse, Wisconsin
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Localized Unresectable Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
Location: La Crosse, Wisconsin
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: La Crosse, Wisconsin
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
Location: La Crosse, Wisconsin
- Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Conditions: Lymphoma
Location: La Crosse, Wisconsin
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Lacrosse, Wisconsin
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: La Crosse, Wisconsin
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: La Crosse, Wisconsin
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: La Crosse, Wisconsin
- Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Conditions: Light Chain Deposition Disease - Smoldering Multiple Myeloma
Location: La Crosse, Wisconsin
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Conditions: Adenocarcinoma of the Esophagus - Adenocarcinoma of the Gastroesophageal Junction - Stage IB Esophageal Cancer - Stage IIA Esophageal Cancer - Stage IIB Esophageal Cancer - Stage IIIA Esophageal Cancer - Stage IIIB Esophageal Cancer
Location: La Crosse, Wisconsin
- Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
Conditions: Prostate Cancer
Location: La Crosse, Wisconsin
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-re
Conditions: Herpes Zoster
Location: La Crosse, Wisconsin
- Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia - Untreated Adult Acute Lymphoblastic Leukemia
Location: La Crosse, Wisconsin
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma - Stage IIIB Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
Location: La Crosse, Wisconsin
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: La Crosse, Wisconsin
- Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma
Conditions: Non-Hodgkins Lymphoma
Location: LaCrosse, Wisconsin
- Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-S
Conditions: Lung Cancer
Location: La Crosse, Wisconsin
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: La Crosse, Wisconsin
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: La Crosse, Wisconsin
- A Study of Avastin (Bevacizumab) in Combination With Standard of Care Treatment in Patients With Lung Cancer
Conditions: Non-Small Cell Lung Cancer
Location: La Crosse, Wisconsin
- Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or
Conditions: Cognitive/Functional Effects - Fatigue - Neurotoxicity - Recurrent Grade 1 Follicular Lymphoma - Recurrent Grade 2 Follicular Lymphoma - Recurrent Grade 3 Follicular Lymphoma - Recurrent Mantle Cell Lymphoma - Recurrent Marginal Zone Lymphoma - Recurrent
Location: La Crosse, Wisconsin
- Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Conditions: Tourette's Disorder
Location: La Crosse, Wisconsin
- Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
Conditions: Idiopathic Thrombocytopenic Purpura - Thrombocytopenia - Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) - Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) - Thrombocytopen
Location: La Crosse, Wisconsin
- A Multi-Center, Randomized, Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal
Conditions: Keratoconus - Corneal Ectasia
Location: La Crosse, Wisconsin
- Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcom
Conditions: Sarcoma
Location: La Crosse, Wisconsin
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: La Crosse, Wisconsin
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: La Crosse, Wisconsin
- Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Conditions: Lupus Nephritis
Location: Onalaska, Wisconsin
- Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
Location: La Crosse, Wisconsin
- Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With SAR236553 (REGN727) (ODYSSEY Outcomes)
Conditions: Acute Coronary Syndrome
Location: Lacrosse, Wisconsin
- Tailored Antiplatelet Therapy Following PCI
Conditions: Coronary Artery Disease - Acute Coronary Syndrome - Stenosis
Location: LaCrosse, Wisconsin
- Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
Conditions: Metastatic Breast Cancer
Location: Lacrosse, Wisconsin
|